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Abstract Inactivation of the Staphylococcus aureus tri-
carboxylic acid (TCA) cycle delays the resolution of cuta-
neous ulcers in a mouse soft tissue infection model. In this
study, it was observed that cutaneous lesions in mice
infected with wild-type or isogenic aconitase mutant
S. aureus strains contained comparable inflammatory infil-
trates, suggesting the delayed resolution was independent of
the recruitment of immune cells. These observations led
us to hypothesize that staphylococcal metabolism can
modulate the host immune response. Using an in vitro
model system involving RAW 264.7 cells, the authors
observed that cells cultured with S. aureus aconitase mutant
strains produced significantly lower amounts of nitric oxide
(NO•) and an inducible nitric oxide synthase as compared to
those cells exposed to wild-type bacteria. Despite the
decrease in NO• synthesis, the expression of antigen-pre-
sentation and costimulatory molecules was similar in cells
cultured with wild-type and those cultured with aconitase
mutant bacteria. The data suggest that staphylococci can
evade innate immune responses and potentially enhance
their ability to survive in infected hosts by altering their
metabolism. This may also explain the occurrence of TCA
cycle mutants in clinical S. aureus isolates.
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Introduction
Staphylococcus aureus is a gram-positive bacterium capa-
ble of surviving extreme environmental conditions and
causing severe infections in both immunocompetent and
immunodeficient individuals. It is estimated that worldwide
S. aureus colonize, both transiently and persistently, two
billion people at any given time [1]. During an infection,
phagocytes recognize bacteria through toll-like receptor
(TLR)-2 and produce bactericidal oxidants such as, reac-
tive oxygen species (ROS) and nitric oxide (NO•), via
nicotinamide adenine dinucleotide phosphate-oxidase,
myeloperoxidase, and inducible nitric oxide synthase
(iNOS) [2–4]. Despite the presence of bactericidal oxi-
dants, staphylococci can survive in macrophages through
robust anti-oxidant defense mechanisms such as carotenoid
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pigments, superoxide dismutases, manganese homeostasis,
and catalases [5]. In addition, it was recently shown that
S. aureus adapts to nitrosative stress by expressing the
NO•-inducible L-lactate dehydrogenase (ldh) as one
mechanism to evade the bactericidal effects of NO• [6].
The regulation of virulence in S. aureus is complex,
involving the agr quorum-sensing system/riboregulator
RNAIII, the SarA family of regulators, and an alternative
sigma factor (rB) [7]. In addition to these regulatory ele-
ments, the authors have demonstrated a causal relationship
between tricarboxylic acid (TCA) cycle activity and viru-
lence factor synthesis [7, 8]. During those studies, the
authors created a TCA cycle mutant of S. aureus by
inactivating aconitase and demonstrated that mice infected
with this TCA cycle mutant strain required a longer time to
develop cutaneous ulcers and to resolve the infection as
compared to mice infected with wild-type (wt) strain [7].
These observations led us to investigate function of the
TCA cycle in the host-pathogen interaction.
Materials and methods
Bacterial strains and growth conditions
Staphylococcus aureus wt strains UAMS-1 and SA564 and
the isogenic aconitase mutant strains UAMS-1-acnA and
SA564-acnA have been described [7, 9]. Bacteria were
grown in tryptic soy broth (TSB; BD Biosciences, San
Jose, CA) or on TSB-containing agar (15 g per l) at 37C
with a flask volume-to-medium ratio of 10:1 aerated by
shaking at 225 rpm.
Mouse soft-tissue infection model and histology
Immunocompetent, hairless outbred mice (Crl:SKH1-
hrBR•SKH1) were procured from the Charles River Lab-
oratories International (Wilmington, MA). The mice were
maintained in accordance with the guidelines of the Animal
Care and Use Committee at Rocky Mountain Laboratories,
Hamilton, MT.
Exponential growth phase bacteria (O.D.600 & 1.0;
25 ml) were harvested by centrifugation, washed two times
with ice-cold phosphate buffered saline (PBS), centrifuged,
suspended in 20 ml PBS, and frozen at -80C until use.
Prior to use and at the time of inoculation, the colony
forming units (CFU) per ml were determined. Mice were
inoculated subcutaneously in the dorsal neck region with
5 9 107 CFU and monitored for the development and
progression of cutaneous ulcers at the sites of infection [7].
A total of 40 animals were used with five mice per group,
each inoculated with either wt or mutant bacteria. At 3, 6,
24, and 48 h postinfection, mice were sacrificed and skin
samples were taken from injection sites and fixed by
immersion in 10% phosphate buffered formalin. Tissues
were sectioned in 5 lM thickness and stained with hema-
toxylin and eosin [H and E; 10] and evaluated for inflam-
matory changes such as abscessation, epidermitis, and
epidermal and dermal necrosis.
Intracellular detection of ROS and NO• by flow
cytometry
The bacterial suspensions were prepared to a final concen-
tration of 1 9 108 CFU per ml in RPMI supplemented with
50% human serum to opsonize bacteria at 37C for 30 min.
After pelleting, the bacteria were washed with 19 endo-
toxin-free PBS and suspended in DMEM containing 10%
fetal bovine serum (FBS). RAW 264.7 cells (clone, TIB-71)
obtained from American Type Culture Collection (Manas-
sas, VA) were maintained in antibiotic-free DMEM sup-
plemented with 10% FBS, hereafter called growth medium.
To determine intracellular production of ROS and NO• in
RAW 264.7 cells exposed to bacteria, 5-(and-6)-chloro-
methyl-20,70-dichlorodihydrofluorescein diacetate acetyl
ester (CM-H2DCFDA) and 4-amino-5-methylamino-2
0,
70-difluorofluorescein (DAF-FM; Invitrogen, Eugene, CA)
were used as ROS and NO• indicators, respectively [11–13].
In brief, 100 ll each of RAW 264.7 cells (4 9 106 per ml)
and bacteria (2 9 107 per ml) were plated in 96-well plates
at a 1:5 ratio, and the plates were incubated at 37C for 6 h.
The oxidation sensitive dyes CM-H2DCFDA and DAF-FM
were added at various concentrations (0–1 lM) during the
last 20 min of incubation, and the cells were washed twice
with 19 PBS. After staining the cells with a cell death
marker, 7-aminoactinomycin D (7-AAD; Invitrogen), cells
were acquired by flow cytometry (FC; FACScan, BD Bio-
sciences), and the fluorescence intensity of live cells
(7-AAD-) positive for CM-H2DCFDA and DAF-FM was
analyzed by Flow Jo software (Tree Star, Ashland, OR).
Analysis of iNOS mRNA expression
RAW 264.7 cells (6 9 106) and the bacteria (3 9 107) were
plated in 6-well plates at a 1:5 ratio in 3 ml of growth
medium, and the plates were incubated for 6 h. In addition,
lipopolysaccharide (LPS) (100 ng per ml) was used as a
positive control [14]. To extract RNA, the medium was
removed and the cells were lysed using RLT buffer con-
taining guanidium thiocyanate (Qiagen, RNeasy kit,
Valencia, CA), and the samples were treated with RNAse-
free DNAse I according to the manufacturer’s recommen-
dations (Qiagen). To make certain that the RNA samples
were free of residual DNA, a second round of DNAse
digestion was performed using amplification grade DNAse I
(Invitrogen), and cDNAs were synthesized utilizing
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Superscript III reverse transcriptase kit as recommended
(Invitrogen). First, it was qualitatively verified the expres-
sion of iNOS mRNA by PCR, the levels of which were
compared with an endogenous control, glyceraldehyde
3-phosphate dehydrogenase (GAPDH) mRNA, using a
Gradient Thermal cycler (Eppendorf, Hauppauge, NY) as
described [15]. The primer sets used were: iNOS-forward,
50 CCTCCTCCACCCTACCAAGT 30; iNOS-reverse, 50
CACCCAAAGTGCTTCAGTCA 30; GAPDH-forward, 50
CGGCAAATTCAACGGCACAGTCAA 30; GAPDH-
reverse, 50 CTTTCCAGAGGGGCCATCCACAG 30. The
PCR products were stained with ethidium bromide and
resolved in 1% agarose gel electrophoresis. Second, it was
quantitatively analyzed the relative fold induction of iNOS
mRNA expression utilizing commercially obtained TaqMan
PCR probes and primers (ABI Biosystems, Carlsbad, CA)
using an iCycler (Bio-Rad Laboratories, Hercules, CA). The
cDNAs derived from three replicates for each treatment
group were used for analysis, and the fold induction of iNOS
mRNA expression was calculated by normalizing to GAP-
DH mRNA [15, 16].
Detection of surface molecules by flow cytometry
RAW 264.7 cells and the bacteria were plated as above at a
1:5 ratio, and after 6 h of incubation, the cells were har-
vested and stained with antibodies for TLR-2, CD80,
CD86, major histocompatibility complex (MHC) class II,
CD40 (eBioscience, San Diego, CA), and 7-AAD. The
clones of the respective antibodies were 6C2, 16-10A1,
GL1, M5/114.15.2, and 1C10. The reaction mixtures were
incubated for 20 min on ice, and the cells were washed and
acquired by FC (FACScan). Percentages of cells positive
for each marker were then determined in the live
(7-AAD-) subset.
Intracellular cytokine detection
RAW 264.7 cells and the bacteria were plated in 6-well
plates at 1:5 ratio in growth medium. After incubating for
2.5 h, the cultures were supplemented with 2 mM
monensin [Golgi stop, BD Biosciences; 10, 17] and incu-
bated further for 4 h. It was also used cells in medium
Fig. 1 Histological evaluation
of skin samples harvested from
mice infected with wt and
aconitase mutant S. aureus. Skin
samples were harvested from
mice infected with wt or mutant
S. aureus at the indicated time
intervals postinfection, and the
cutaneous sections were stained
with H and E to evaluate
inflammatory changes (arrows).
Note similar suppurative
dermatitis at 3 h postinfection
with wt or mutant bacteria. At
6 h, suppuration and bacterial
colonization was more
extensive in mice infected with
wt than with mutant bacteria.
Tissues sampled at 48 h from
mice infected with wt but not
mutant bacteria consistently
showed epidermal and dermal
necrosis, including pyknosis and
karyorrhexis of dermal
fibroblasts (shown in circles).
Original magnification, 9400
(bar 20 mM)
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alone or cells treated with LPS (1 lg per ml) as negative
and positive controls, respectively. At the end of incuba-
tion, cells were harvested and washed once with 19 PBS.
After fixation and permeabilization, the cells were stained
with antibodies for interleukin (IL)-1b (rabbit polyclonal),
IL-6 (clone, MPS-20F3), and tumor necrosis factor (TNF)-
a (clone, MP6-XT22) and their respective isotype controls
(eBioscience) and 7-AAD. Cells were acquired by FC, and
frequencies of cytokine-secreting cells were then enumer-
ated in live (7-AAD-) cell populations [10].
Statistics
Differences in the levels of iNOS mRNA, ROS, NO•, and
cytokine induction in RAW 264.7 cells cultured with wt or
mutant strains of S. aureus were analyzed by Student’s
t test. To determine differences in inflammatory changes in
cutaneous tissues at each time point postinfection with wt
or mutant bacteria, skin sections were examined for
abscessation, epidermitis, and necrosis and the differences
between groups were compared using one-tailed Fisher’s
exact test. P B 0.05 values were considered significant.
Results and discussion
Aconitase inactivation in S. aureus altered the temporal
synthesis of secreted virulence and cell-associated adhe-
sion factors [7]. Using a mouse soft tissue infection model,
mice infected with an aconitase mutant strain (SA564-
acnA) took longer to develop lesions, re-epithelialize the
sites of infection, and to regain their pre-inoculation body
weight relative to mice infected with an isogenic wild-type
strain (SA564) [7], suggesting that disruption of the TCA
cycle in S. aureus alters the host’s response to the bacteria.
In this report, it was demonstrate that S. aureus metabolism
does not affect the recruitment of inflammatory cells but
does alter the host immune response, raising the possibility
that one mechanism by which S. aureus evades the immune
response is by altering its central metabolism. Support for
Fig. 2 RAW 264.7 cells
exposed to aconitase-mutant
S. aureus produce less nitric
oxide than wt strains. RAW
264.7 cells were cultured with
wt or aconitase-inactivated
S. aureus mutants at 1:5 ratio
for 6 h at 37C. The cultures
were then exposed to DAF-FM
during the last 20 min of
incubation as an NO indicator.
After washing, cells were
stained with 7-AAD and
acquired by FC. Percentages of
DAF-FM? cells were then
determined in the live
(7-AAD-) subset.
Representative data from four
individual experiments are
shown
Table 1 Induction of reactive oxygen species and nitric oxide by wild type and aconitase-mutant S. aureus in RAW 264.7 cells
Dye (lM) Medium control Wild typea (UAMS-1) Mutanta (UAMS-1-acnA) Wild typeb (SA-564) Mutantb (SA-564-acnA)
ROS 0 0.04 ± 0.04 1.41 ± 1.17 1.6 ± 1.29 0.75 ± 0.66 1.63 ± 1.22
0.5 0.19 ± 0.085 34.36 ± 6.18 23.00 ± 5.43 36.18 ± 3.17 29.07 ± 7.64
1 0.39 ± 0.15 62.78 ± 10.00 50.16 ± 8.44 71.48 ± 2.16 54.12 ± 5.92
NO 0 0.21 ± 0.11 3.08 ± 0.36 2.16 ± 0.51 1.20 ± 0.23 2.60 ± 0.39
0.5 0.12 ± 0.02 23.01 ± 2.13 13.54 ± 1.88 29.37 ± 4.59 18.03 ± 1.13
1 0.12 ± 0.05 39.41 ± 4.02 27.55 ± 5.33 50.20 ± 6.28 34.43 ± 2.99
Numbers are Mean ± SEM (n = 4)
a,  P = 0.01
b,  P = 0.04
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this possibility was recently reported by Richardson et al.
[6]. To test this possibility, skin samples were harvested
from mice infected with S. aureus wt (SA564) or aconitase
mutant (SA654-acnA) strains and assessed by histological
evaluation for inflammatory changes. At 3 h postinfection,
histological evaluation of skin sections from mice infected
with either wt or aconitase mutant strains had identical
inflammatory infiltrates, predominantly comprised of neu-
trophils and a few macrophages (Fig. 1). As the infection
progressed, cellular infiltrates and bacteria were less pro-
nounced in tissues sampled at 6, 24, and 48 h from mice
infected with strain SA654-acnA as compared to strain
SA564. Notably, skin samples obtained from mice infected
with wt (10/10) but not mutant bacteria (4/10) consistently
showed necrosis of the epidermis and dermis beyond 24 h
(P = 0.0054). Similarly, at 48 h there was remarkable
epidermitis in mice infected with wt bacteria (5/5) but not
in the aconitase mutant (1/5)-infected mice (P = 0.024).
These observations indicate the host recognizes TCA cycle
inactivated bacteria and recruits phagocytes to the sites of
infection; however, it does not address whether differences
in the activation state of infiltrates exist. To address this
question, an in vitro culture system using the mouse
macrophage cell line, RAW 264.7, was established to
examine the production of bactericidal oxidants in response
to wt and mutant strains of S. aureus at a single cell level
by FC. Specifically, CM-H2DCFDA was used as a broad
range indicator of ROS, such as hydrogen peroxide,
hydroxyl radicals, peroxyl radicals, and peroxynitrite
anions, while NO• production was assessed using DAF-FM
[11–13]. Figure 2 and Table 1 show that cells cultured with
S. aureus aconitase mutants UAMS-1-acnA and SA564-
acnA produced significantly lower amounts of NO• as
indicated by the lower frequency of DAF-FM-positive cells
when compared with the cells exposed to wt bacteria
(P \ 0.05). Similarly, cells cultured with wild-type
S. aureus strains produced greater amounts of ROS relative
to the aconitase mutant strains when analyzed using CM-
H2DCFDA-positive cells (Table 1). Taken together, these
data suggest that TCA cycle inactivation does not alter the
recruitment of phagocytes; however, it does alter the acti-
vation of those infected phagocytes.
The decreased synthesis of NO• by RAW 264.7 cells
exposed to aconitase mutant strains UAMS-1-acnA and
SA564-acnA relative to the isogenic wild-type strains
(Fig. 2) could occur at the level of transcription or by
bacterial interference with the iNOS protein-mediated NO•
synthesis [18, 19]. To determine if the decreased produc-
tion of NO• in cells exposed to aconitase mutant strains
was due to a decrease in iNOS transcription, iNOS mRNA
expression was analyzed by RT-PCR in cells exposed to wt
or mutant bacteria using LPS as a positive control. As
shown in Fig. 3, both wt strains (UAMS-1 and SA564)
induced the expression of iNOS mRNA in RAW 264.7
cells; however, iNOS mRNA expression was significantly
decreased in cells exposed to the bacterial mutants
(P B 0.05). Together these data indicate that aconitase
inactivation in S. aureus suppresses iNOS synthesis,
resulting in decreased NO• production. This has important
implications for the host-pathogen interaction because NO•
is a critical mediator of bacterial killing [5, 20] and when
produced in excess, NO• can contribute to tissue damage
during inflammation [21, 22]. These observations and the
fact that naturally occurring S. aureus TCA cycle mutants
have been reported [23], suggest there is immune system
selective pressure on bacterial TCA cycle activity. Any
selective pressure that results in decreased TCA cycle
activity will create metabolic signals within the bacteria
[24] that result in enhanced bacterial survival, decreased
Fig. 3 RAW 264.7 cells exposed to aconitase-mutant S. aureus
express lower amounts of iNOS mRNA than wt strains. a Qualitative
RT-PCR analysis. RAW 264.7 cells were cultured with wt or
aconitase-inactivated S. aureus mutants at 1:5 ratio for 6 h at 37C.
After washing, total RNA was extracted, and synthesized cDNAs and
iNOS mRNA expression was examined by PCR using sequence
specific primers. The ethidium bromide-stained PCR products were
resolved in 1% agarose gel electrophoretic analysis, and shown are
the expected sizes of iNOS (top panel) and GAPDH (bottom panel)
PCR products. b Quantitative analysis by TaqMan PCR. cDNAs were
generated from RAW 264.7 cells cultured with wt or aconitase-
mutant bacteria as above and the relative fold induction of iNOS
mRNA expression was determined by TaqMan PCR analysis by
normalizing the expression levels of iNOS mRNA to GAPDH
mRNA. Mean ± SEM values are shown (n = 3)
Mol Cell Biochem (2011) 355:75–82 79
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virulence factor synthesis, and an alteration of bacterial
metabolism [7, 25]; thus, staphylococci may use to evade
the host’s defense mechanisms. Finally, these observations
may explain the long duration needed to establish and
resolve infections in mice inoculated with aconitase mutant
bacteria [7].
Transcription of iNOS and the synthesis of NO• are
regulated by inflammatory cytokines [26–28]. To deter-
mine if aconitase mutant strains altered the production of
inflammatory cytokines, the authors enumerated by FC the
frequencies of cells producing IL-1b, IL-6, and TNF-a at
the single cell level. The expression of IL-1b and TNF-a in
RAW 264.7 cells infected with wt and those infected with
mutant strains was similar; however, the number of IL-6-
secreting cells was approximately twofold lower in cells
cultured with UAMS-1-acnA but not strain SA564-acnA
(Fig. 4). Since both mutant strains carry the same muta-
tions, it was anticipated that cytokine responses would be
similar; however, S. aureus strain-dependent variations in
host immune responses are common [29, 30]. Tradition-
ally, IL-6 is regarded as one of the prototypical inflam-
matory cytokines produced in response to S. aureus
infection [31], but recent reports indicate that IL-6 can also
have an anti-inflammatory function [32, 33]. Although the
data provide an association between aconitase inactivation
and decreased secretion of IL-6, additional studies are
required to investigate whether suppressed IL-6 production
favors bacterial survival or their destruction.
Upon entry into a host, S. aureus produce numerous
virulence determinants [34, 35] that can induce phagocyte
recognition through TLR-2 via pathogen-associated
molecular patterns. In addition, during the formation of an
abscess, T cells are activated through the CD28-CD80/
CD86 costimulation pathway [36], while CD4 helper cells
interact with macrophages via the CD40–CD40 ligand
pathway to potentiate their bactericidal effects [37].
S. aureus aconitase mutants have been shown to decrease
synthesis of virulence determinants such as lipase (geh),
enterotoxin C (sec), a-toxin (hla), b-toxin (hlb), d-toxin
(hld), rB (sigB), capsule (cap), and clumping factor (clfA)
[7]; thus, it is possible that antigen presentation could be
affected by aconitase inactivation. To determine if
the decreased synthesis of virulence determinants by the
aconitase mutant strains affect adaptive immunity, the
Fig. 4 RAW 264.7 cells exposed to aconitase-mutant S. aureus
produce lower amounts of IL-6 than wt strains. RAW 264.7 cells were
incubated with wt or aconitase-inactivated S. aureus mutants at 1:5
ratio for 2.5 h in growth medium, and after adding Golgistop, cells
were further incubated for 4 h. Cells were then stained with 7-AAD,
fixed and permeabilized, followed by staining with anti-IL-6 or
isotype control. Cells were acquired by FC, and the percentage of
IL-6-secreting cells was enumerated in the live (7-AAD-) subset.
Representative data from three individual experiments are shown
Table 2 Comparative analysis of antigen-presentation and costimulatory molecules induced by wild type and aconitase-mutant S. aureus in
RAW 264.7 cells
Medium control LPS (100 ng/ml) Wild type (UAMS-1) Mutant (UAMS-1-acnA) Wild type (SA-564) Mutant (SA-564-acnA)
TLR-2 99.96 ± 0.01 99.92 ± 0.024 97.98 ± 0.77 98.11 ± 0.47 98.51 ± 0.70 98.33 ± 0.32
CD80 59.16 ± 8.77 70.65 ± 6.13 90.52 ± 3.08 83.90 ± 8.48 88.8 ± 3.62 78.22 ± 12.44
CD86 73.24 ± 13.38 76.58 ± 12.06 72.96 ± 12.74 64.24 ± 16.23 69.84 ± 13.71 71.56 ± 13.67
MHC-II 0.57 ± 0.46 2.42 ± 1.94 1.49 ± 0.46 1.57 ± 0.36 1.28 ± 0.22 1.047 ± 0.62
CD40 6.05 ± 2.18 81.35 ± 2.89 8.97 ± 1.71 7.77 ± 1.00 8.51 ± 0.83 8.34 ± 0.82
Numbers are Mean ± SEM (n = 3)
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authors assayed for the presence of antigen-presentation
(MHC class-II) and costimulatory molecules (CD80,
CD86, and CD40; Table 2). Both the wt and mutant strains
of S. aureus induced CD80, MHC class-II, and CD40
molecules in RAW 264.7 cells to a similar level. Although
the expression of CD80 tended to be lower in cells cultured
with aconitase mutant strains as compared to those cultured
with the wt bacteria, the differences were not significant.
These data strongly suggest that phagocyte antigen pre-
sentation is independent of S. aureus TCA cycle activity.
Staphylococcus aureus have evolved several mecha-
nisms that favor their survival in infected hosts. These
include interference with chemotaxis, opsonin-mediated
phagocytosis, and detoxification of bactericidal oxidants
[5]. Recently it was shown that staphylococci can adapt to
nitrosative stress and maintain virulence by promoting the
production of lactate through NO-inducible ldh [6]. Nor-
mally, bacteria induce lactate dehydrogenases when the
oxidation of NADH through the respiratory chain is
inhibited. In the case of the S. aureus NO•-inducible ldh,
NO• prevents the respiratory chain from oxidizing NADH
and forces carbon through an NO•-inducible ldh to oxidize
NADH [6, 38, 39]. Similarly, inactivation of the TCA cycle
redirects carbon away from the TCA cycle and into over-
flow metabolism pathways, including ldh. In other words,
when phagocyte-produced NO• decreases bacterial respi-
ratory activity, NADH accumulates, synthesis of the NO•-
inducible ldh is activated, and carbon flow-through the
TCA cycle is redirected into ldh, allowing for the oxidation
of NADH. Concomitantly, the decrease in TCA cycle
activity results in a decrease in phagocyte-produced NO•
(Fig. 2 and Table 1) and an increase in S. aureus survival
[7]. In total, it is tempting to speculate that mammalian
immune responses evolved to recognize bacterial meta-
bolic signatures, and this has resulted in the repurposing of
bacterial metabolic pathways to suppress the host’s ability
to mount an effective innate immune response.
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